Bolton Et Al. Supplement
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
TZAP Mutation Leads to Poor Prognosis of Patients † with Breast Cancer
medicina Article TZAP Mutation Leads to Poor Prognosis of Patients y with Breast Cancer 1, 2, 3 2, 1, Yu-Ran Heo z, Moo-Hyun Lee z, Sun-Young Kwon , Jihyoung Cho * and Jae-Ho Lee * 1 Department of Anatomy, School of Medicine, Keimyung University, Daegu 42601, Korea; [email protected] 2 Department of Surgery, School of Medicine, Keimyung University, Dongsan Medical Center, Daegu 42601, Korea; [email protected] 3 Department of Pathology, School of Medicine, Keimyung University, Dongsan Medical Center, Daegu 42601, Korea; [email protected] * Correspondence: [email protected] (J.C.); [email protected] (J.-H.L.); Tel.: +82-53-580-3838 (J.C.); +82-53-580-3833 (J.-H.L.); Fax: +82-53-580-3835 (J.C. & J.-H.L.) This article was previously presented on the Breast Cancer Symposium in San Antonio, Texas, USA, y on 4–8 Dec. 2018. These authors contributed equally to this work. z Received: 1 October 2019; Accepted: 8 November 2019; Published: 18 November 2019 Abstract: Background and Objectives: ZBTB48 is a telomere-associated factor that has been renamed as telomeric zinc finger-associated protein (TZAP). It binds preferentially to long telomeres, competing with telomeric repeat factors 1 and 2. Materials and Methods: We analyzed the TZAP mutation in 128 breast carcinomas (BCs). In addition, its association with telomere length was investigated. Results: The TZAP mutation (c.1272 G > A, L424L) was found in 7.8% (10/128) of the BCs and was associated with the N0 stage. BCs with the TZAP mutation had longer telomeres than those without this mutation. -
Early Diagnosis of Colorectal Cancer Via Plasma Proteomic Analysis of CRC and Advanced Adenomatous Polyp
Gastroenterology and Hepatology From Bed to Bench. ORIGINAL ARTICLE ©2019 RIGLD, Research Institute for Gastroenterology and Liver Diseases Early diagnosis of colorectal cancer via plasma proteomic analysis of CRC and advanced adenomatous polyp Setareh Fayazfar1, Hakimeh Zali2, Afsaneh Arefi Oskouie1, Hamid Asadzadeh Aghdaei3, Mostafa Rezaei Tavirani4, Ehsan Nazemalhosseini Mojarad5 1Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran 2School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran 3Basic and Molecular Epidemiology of Gastroenterology Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran 4Proteomics Research Center, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran 5Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran ABSTRACT Aim: This paper aimed to identify new candidate biomarkers in blood for early diagnosis of CRC. Background: Colorectal cancer (CRC) is the third most widespread malignancies increasing globally. The high mortality rate associated with colorectal cancer is due to the delayed diagnosis in an advanced stage while the metastasis has occurred. For better clinical management and subsequently to reduce mortality of CRC, early detection biomarkers are in high demand. -
The Function and Evolution of C2H2 Zinc Finger Proteins and Transposons
The function and evolution of C2H2 zinc finger proteins and transposons by Laura Francesca Campitelli A thesis submitted in conformity with the requirements for the degree of Doctor of Philosophy Department of Molecular Genetics University of Toronto © Copyright by Laura Francesca Campitelli 2020 The function and evolution of C2H2 zinc finger proteins and transposons Laura Francesca Campitelli Doctor of Philosophy Department of Molecular Genetics University of Toronto 2020 Abstract Transcription factors (TFs) confer specificity to transcriptional regulation by binding specific DNA sequences and ultimately affecting the ability of RNA polymerase to transcribe a locus. The C2H2 zinc finger proteins (C2H2 ZFPs) are a TF class with the unique ability to diversify their DNA-binding specificities in a short evolutionary time. C2H2 ZFPs comprise the largest class of TFs in Mammalian genomes, including nearly half of all Human TFs (747/1,639). Positive selection on the DNA-binding specificities of C2H2 ZFPs is explained by an evolutionary arms race with endogenous retroelements (EREs; copy-and-paste transposable elements), where the C2H2 ZFPs containing a KRAB repressor domain (KZFPs; 344/747 Human C2H2 ZFPs) are thought to diversify to bind new EREs and repress deleterious transposition events. However, evidence of the gain and loss of KZFP binding sites on the ERE sequence is sparse due to poor resolution of ERE sequence evolution, despite the recent publication of binding preferences for 242/344 Human KZFPs. The goal of my doctoral work has been to characterize the Human C2H2 ZFPs, with specific interest in their evolutionary history, functional diversity, and coevolution with LINE EREs. -
High-Throughput Bioinformatics Approaches to Understand Gene Expression Regulation in Head and Neck Tumors
High-throughput bioinformatics approaches to understand gene expression regulation in head and neck tumors by Yanxiao Zhang A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy (Bioinformatics) in The University of Michigan 2016 Doctoral Committee: Associate Professor Maureen A. Sartor, Chair Professor Thomas E. Carey Assistant Professor Hui Jiang Professor Ronald J. Koenig Associate Professor Laura M. Rozek Professor Kerby A. Shedden c Yanxiao Zhang 2016 All Rights Reserved I dedicate this thesis to my family. For their unfailing love, understanding and support. ii ACKNOWLEDGEMENTS I would like to express my gratitude to Dr. Maureen Sartor for her guidance in my research and career development. She is a great mentor. She patiently taught me when I started new in this field, granted me freedom to explore and helped me out when I got lost. Her dedication to work, enthusiasm in teaching, mentoring and communicating science have inspired me to feel the excite- ment of research beyond novel scientific discoveries. I’m also grateful to have an interdisciplinary committee. Their feedback on my research progress and presentation skills is very valuable. In particular, I would like to thank Dr. Thomas Carey and Dr. Laura Rozek for insightful discussions on the biology of head and neck cancers and human papillomavirus, Dr. Ronald Koenig for expert knowledge on thyroid cancers, Dr. Hui Jiang and Dr. Kerby Shedden for feedback on the statistics part of my thesis. I would like to thank all the past and current members of Sartor lab for making the lab such a lovely place to stay and work in. -
Gene Mapping and Medical Genetics
J Med Genet: first published as 10.1136/jmg.24.8.451 on 1 August 1987. Downloaded from Gene mapping and medical genetics Journal of Medical Genetics 1987, 24, 451-456 Molecular genetics of human chromosome 16 GRANT R SUTHERLAND*, STEPHEN REEDERSt, VALENTINE J HYLAND*, DAVID F CALLEN*, ANTONIO FRATINI*, AND JOHN C MULLEY* From *the Cytogenetics Unit, Adelaide Children's Hospital, North Adelaide, South Australia 5006; and tUniversity of Oxford, Nuffield Department of Clinical Medicine, John Radcliffe Hospital, Headington, Oxford OX3 9DU. SUMMARY The major diseases mapped to chromosome 16 are adult polycystic kidney disease and those resulting from mutations in the a globin complex. There are at least six other less important genetic diseases which map to this chromosome. The adenine phosphoribosyltransferase gene allows for selection of chromosome 16 in somatic cell hybrids and a hybrid panel is available which segments the chromosome into six regions to facilitate gene mapping. Genes which have been mapped to this chromosome or which have had their location redefined since HGM8 include APRT, TAT, MT, HBA, PKDI, CTRB, PGP, HAGH, HP, PKCB, and at least 19 cloned DNA sequences. There are RFLPs at 13 loci which have been regionally mapped and can be used for linkage studies. Chromosome 16 is not one of the more extensively have been cloned and mapped to this chromosome. mapped human autosomes. However, it has a Brief mention will be made of a hybrid cell panel http://jmg.bmj.com/ number of features which make it attractive to the which allows for an efficient regional localisation of gene mapper. -
ZBTB10 Binds the Telomeric Variant Repeat TTGGGG and Interacts with TRF2
1896–1907 Nucleic Acids Research, 2019, Vol. 47, No. 4 Published online 10 January 2019 doi: 10.1093/nar/gky1289 ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 Alina Bluhm1, Nikenza Viceconte1, Fudong Li2, Grishma Rane3, Sandra Ritz4, Suman Wang2, Michal Levin1, Yunyu Shi2, Dennis Kappei 3,* and Falk Butter 1,* 1Quantitative Proteomics, Institute of Molecular Biology, 55128 Mainz, Germany, 2Hefei National Laboratory for Physical Sciences at Microscale and School of Life Sciences, University of Science and Technology of China, 230027 Hefei, Anhui, China, 3Cancer Science Institute of Singapore, National University of Singapore, Singapore 117599 and 4Microscopy Core Facility, Institute of Molecular Biology, 55128 Mainz, Germany Downloaded from https://academic.oup.com/nar/article/47/4/1896/5284933 by guest on 27 September 2021 Received August 07, 2018; Revised November 27, 2018; Editorial Decision December 13, 2018; Accepted December 14, 2018 ABSTRACT an important role in end protection by inducing and stabi- lizing t-loop structures (3–5). Thereby, chromosomal ends Telomeres are nucleoprotein structures at the ends are safeguarded from nucleolytic degradation and protected of linear chromosomes and present an essential fea- from the DNA damage response and repair activities such ture for genome integrity. Vertebrate telomeres usu- as non-homologous end joining. TRF2 and RAP1 together ally consist of hexameric TTAGGG repeats, however, repress homology directed repair by preventing telomeric in cells that use the alternative lengthening of telom- localization of PARP1 and SLX4 (6). TRF2 has further- eres (ALT) mechanism, variant repeat sequences more been shown to repress ATM kinase activity at telom- are interspersed throughout telomeres. -
The T(6;16)(P21;Q22) Chromosome Translocation in the Lncap Prostate Carcinoma Cell Line Results in a Tpc/Hpr Fusion Gene'
CANCERRESEARCH56.728-732.February15. 9961 Advances in Brief The t(6;16)(p21;q22) Chromosome Translocation in the LNCaP Prostate Carcinoma Cell Line Results in a tpc/hpr Fusion Gene' Maria Luisa Veronese, Florencia Bulinch, Massimo Negrini, and Carlo M. Croce2 Jefferson Cancer Center, Jefferson Cancer Institute and Department of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, Pennsylvania 19107 Abstract level. We have found that the translocation results in fusion of the hpr gene on chromosome 16 to the tpc gene, a novel gene coding for a Very little is known about the molecular and genetic mechanisms protein similar to nbosomal protein 510. involved in prostate cancer.Previousstudieshaveshownfrequent lossof heterozygosity(40%)at chromosomalregions8p, lOq,and 16q,suggesting thepresenceoftumorsuppressorgenesintheseregions.TheLNCaP cell Materials and Methods line, establishedfrom a metastaticlesionof human prostatic adenocarci Rodent-Human Hybrids. The hybrids seriesA9LN were obtainedfrom noma,carries a t(6;16)(p21;q22)translocation.To determinewhether this translocation involved genesimportant in the processof malignant trans thefusionof thehumanprostatecarcinomacellline LNCaPandthemouseA9 formation, weclonedand sequencedthet(6;16) breakpoint ofthis cell line. cell line as previously described (15). PCR analysis with primers from both the Sequenceanalysisshowedthat the breakpoint is within the haptoglobin shortandlongarmsof chromosome16wascarriedout in 1 X PCRbufferwith geneclusteron chromosome16,and that, on chromosome6,the break MgCI2 (Boehringer Mannheim) with 100 ng template DNA, 100 ng each of occurs within a novel gene,tpc, similar to the prokaryotic SlO ribosomal forward and reverseprimer, 250 @Mdeoxynucleotidetriphosphates(Perkin protein gene. The translocation results in the production of a fusion Elmer/Cetus), and 0.5 units of Taq DNA polymerase (Boehringer Mannheim) transcript, tpc/hpr. -
Predicting Environmental Chemical Factors Associated with Disease-Related Gene Expression Data
UCSF UC San Francisco Previously Published Works Title Predicting environmental chemical factors associated with disease-related gene expression data. Permalink https://escholarship.org/uc/item/1kj3j6m8 Journal BMC medical genomics, 3(1) ISSN 1755-8794 Authors Patel, Chirag J Butte, Atul J Publication Date 2010-05-06 DOI 10.1186/1755-8794-3-17 Peer reviewed eScholarship.org Powered by the California Digital Library University of California Patel and Butte BMC Medical Genomics 2010, 3:17 http://www.biomedcentral.com/1755-8794/3/17 RESEARCH ARTICLE Open Access PredictingResearch article environmental chemical factors associated with disease-related gene expression data Chirag J Patel1,2,3 and Atul J Butte*1,2,3 Abstract Background: Many common diseases arise from an interaction between environmental and genetic factors. Our knowledge regarding environment and gene interactions is growing, but frameworks to build an association between gene-environment interactions and disease using preexisting, publicly available data has been lacking. Integrating freely-available environment-gene interaction and disease phenotype data would allow hypothesis generation for potential environmental associations to disease. Methods: We integrated publicly available disease-specific gene expression microarray data and curated chemical- gene interaction data to systematically predict environmental chemicals associated with disease. We derived chemical- gene signatures for 1,338 chemical/environmental chemicals from the Comparative Toxicogenomics Database (CTD). We associated these chemical-gene signatures with differentially expressed genes from datasets found in the Gene Expression Omnibus (GEO) through an enrichment test. Results: We were able to verify our analytic method by accurately identifying chemicals applied to samples and cell lines. Furthermore, we were able to predict known and novel environmental associations with prostate, lung, and breast cancers, such as estradiol and bisphenol A. -
Study of the Effects of in Vivo Telomere Elongation Mechanisms in Cancer and Aging
Universidad Autónoma de Madrid Programa de Doctorado en Biociencias Moleculares Study of the effects of in vivo telomere elongation mechanisms in cancer and aging DOCTORAL THESIS Miguel Ángel Muñoz Lorente Madrid, 2019 DEPARTAMENTO DE BIOLOGÍA MOLECULAR FACULTAD DE CIENCIAS UNIVERSIDAD AUTÓNOMA DE MADRID Study of the effects of in vivo telomere elongation mechanisms in cancer and aging DOCTORAL THESIS Miguel Ángel Muñoz Lorente BSc, MSc The entirety of the work presented in this Thesis has been carried out at the Telomeres and Telomerase Group in the Spanish National Cancer Centre (CNIO, Madrid) under the direction and supervision of Dr. Maria Blasco Marhuenda Madrid, 2019 Summary/ Resumen Summary/Resumen 1. English Short and dysfunctional telomeres are sufficient to induce a persistent DNA damage response at chromosome ends, which leads to the induction of senescence and/or apoptosis and trigger age-related pathologies including a group of diseases known as “telomere syndromes”, and shorter lifespans in mice and humans. In turn, maintenance of longer telomeres owing to telomerase overexpression in adult tissues delays aging and increases mouse longevity. This opens the possibility of using telomerase activation as a potential therapeutic strategy to rescue short telomeres both in telomere syndromes and in age- related diseases. However, telomerase has been found re-activated in most of human cancers making telomerase therapy a potential risk in treating short telomere accumulation. In this regard, telomere elongation avoiding the overexpression of telomerase could be a safer answer to prevent short telomeres delaying or even avoiding short telomere related pathologies. Based on this, the first aim of this thesis is to test the safety of telomerase gene therapy in the context of a cancer prone mouse model. -
The 11Th C2H2 Zinc Finger and an Adjacent C-Terminal Arm Are Responsible for TZAP Recognition of Telomeric DNA Cell Research (2018) 28:130-134
Cell Research (2018) 28:130-134. © 2018 IBCB, SIBS, CAS All rights reserved 1001-0602/18 $ 32.00 LETTER TO THE EDITOR www.nature.com/cr The 11th C2H2 zinc finger and an adjacent C-terminal arm are responsible for TZAP recognition of telomeric DNA Cell Research (2018) 28:130-134. doi:10.1038/cr.2017.141; published online 14 November 2017 Dear Editor, types of subtelomeric DNA [7, 10, 11]. In contrast to the well-defined DNA binding mechanisms of TRF1, TRF2 Telomere length homeostasis, dictating cellular prolif- and HOT1, the mechanisms by which TZAP specifically erative potential, is crucial for proper cellular function. interacts with (sub)telomeric DNA requires further inves- In addition to the well-known telomere shortening during tigation. cell division and lengthening by activation of telomerase We first generated a construct of TZAP that included or an alternative lengthening of telomeres (ALT) mech- Znf9-11 (residues 516-605). Using FP (fluorescence po- anism, telomere length is also subject to regulated rapid larization) assay, we showed that the Znf9-11 construct deletion events referred to as telomere trimming [1]. This displayed a relatively low binding affinity (> 30 µM) to trimming process involves excision of telomeric struc- a double-stranded oligonucleotide containing TTAGGG tures called T-loops, which requires homologous recom- sequence (referred to as TTAGGG probe) (Figure 1B bination proteins XRCC3 and NBS1 [2, 3]. Recent stud- and Supplementary information, Table S1). We then no- ies showed that the balance between telomere trimming ticed that there is an evolutionarily conserved and highly and lengthening determines telomere length in germline basic region (residues 606-620) located immediately and stem cells, suggesting that telomere trimming should C-terminal to Znf11 (Supplementary information, Figure be under stringent control [4, 5]. -
SYNGAP1 Controls the Maturation of Dendrites, Synaptic Function, and Network Activity in Developing Human Neurons
7980 • The Journal of Neuroscience, October 7, 2020 • 40(41):7980–7994 Neurobiology of Disease SYNGAP1 Controls the Maturation of Dendrites, Synaptic Function, and Network Activity in Developing Human Neurons Nerea Llamosas,1 Vineet Arora,1 Ridhima Vij,2,3 Murat Kilinc,1 Lukasz Bijoch,4 Camilo Rojas,1 Adrian Reich,5 BanuPriya Sridharan,6 Erik Willems,7 David R. Piper,7 Louis Scampavia,6 Timothy P. Spicer,6 Courtney A. Miller,1,6 J. Lloyd Holder,2,3 and Gavin Rumbaugh1 1Department of Neuroscience, Scripps Research, Jupiter, Florida 33458, 2Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital, Houston, Texas 77030, 3Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030, 4Laboratory of Neurobiology, BRAINCITY, Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland, 5Center for Computational Biology and Bioinformatics, Scripps Research, Jupiter, Florida 33458, 6Department of Molecular Medicine, Scripps Research, Jupiter, Florida 33458, and 7Cell Biology, Thermo Fisher Scientific, Carlsbad, California 92008 SYNGAP1 is a major genetic risk factor for global developmental delay, autism spectrum disorder, and epileptic encephalopathy. De novo loss-of-function variants in this gene cause a neurodevelopmental disorder defined by cognitive impairment, social-communica- tion disorder, and early-onset seizures. Cell biological studies in mouse and rat neurons have shown that Syngap1 regulates developing excitatory synapse structure and function, with loss-of-function variants driving formation of larger dendritic spines and stronger glu- tamatergic transmission. However, studies to date have been limited to mouse and rat neurons. Therefore, it remains unknown how SYNGAP1 loss of function impacts the development and function of human neurons. -
HKR3 Regulates Cell Cycle Through the Inhibition of Htert In
Journal of Cancer 2020, Vol. 11 2442 Ivyspring International Publisher Journal of Cancer 2020; 11(9): 2442-2452. doi: 10.7150/jca.39380 Research Paper HKR3 regulates cell cycle through the inhibition of hTERT in hepatocellular carcinoma cell lines Sung Hoon Choi1, Kyung Joo Cho1,2, Sung Ho Yun3, Bora Jin1,2, Ha Young Lee3,4, Simon W Ro 1,5, Do Young Kim1,5, Sang Hoon Ahn1,2,5, Kwang-hyub Han1,3,5, Jun Yong Park1,2,5 1. Yonsei Liver Center, Yonsei University College of Medicine, Seoul, Republic of Korea 2. BK21 plus project for medical science, Yonsei University College of Medicine, Seoul, Republic of Korea 3. Division of Bioconvergence Analysis, Drug & Disease Target Team, Korea Basic Science Institute (KBSI), Cheongju, Republic of Korea 4. Bio-Analysis Science, University of Science & Technology (UST), 217 Gajeong-ro, Yuseong-gu, Daejeon, Republic of Korea 5. Department of Internal Medicine, Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Republic of Korea Corresponding author: Department of Internal Medicine, Institute of Gastroenterology, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea. Phone: 82-2-2228-1988; Fax: 82-2-393-6884; E-mail: [email protected] © The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions. Received: 2019.08.16; Accepted: 2020.01.20; Published: 2020.02.10 Abstract Hepatocellular carcinoma is a malignant disease with improved hepatic regeneration and survival, and is activated by human telomere transferase (hTERT).